# Eikon Therapeutics IPO (EIKN): price, date and first-day trading

> Eikon Therapeutics (EIKN) priced its IPO at $18.00 a share and has traded on Nasdaq since Feb 5, 2026.

Canonical: https://massive.com/quote/eikn/ipo
Data as of: 2026-11-19T00:30:02.926Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## EIKN price

| Figure | Value |
| --- | --- |
| Price | $5.17 |
| Change from the IPO price | -71.28% |
| Change today | +0.39% |

## How EIKN did against the market

EIKN against the market, from its first trade at 12:40 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| EIKN from its first trade | -13.14% |
| Against the market (QQQ) | -12.4 pts |

## The IPO scoreboard

EIKN against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Eikon Therapeutics | $381.2M | -5.28% | -17.72% | -19.06% | -39.17% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $16 to $18 |
| IPO price | $18.00 |
| Shares offered | 21.18M |
| Money raised | $381.2M |
| Listing date | Feb 5, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where EIKN ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| EIKN | $280.14M |

## Insider buying and selling after the IPO

From Feb 5, 2026 to Nov 19, 2026, one EIKN insider reported open-market purchases of $1.0M across 1 filing; no open-market sales were filed.

- Tim Kutzkey, 10% owner: bought $1.0M, filed Sep 8, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/eikn/insider-trading.md)

## EIKN news

- [Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress](https://www.globenewswire.com/news-release/2026/10/26/3387904/0/en/eikon-therapeutics-presents-updated-eik1001-data-from-teluride-005-at-the-european-society-for-medical-oncology-congress.html) · GlobeNewswire Inc. · Oct 26, 2026
- [Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress](https://www.globenewswire.com/news-release/2026/10/18/3382951/0/en/eikon-therapeutics-announces-availability-of-seven-abstracts-for-presentation-at-the-european-society-for-medical-oncology-congress.html) · GlobeNewswire Inc. · Oct 18, 2026
- [Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology](https://www.globenewswire.com/news-release/2026/05/30/3303899/0/en/Eikon-Therapeutics-Presents-Data-on-Clinical-Stage-Programs-at-the-2026-Annual-Meeting-of-the-American-Society-of-Clinical-Oncology.html) · GlobeNewswire Inc. · May 30, 2026

## Filings and the company

Material events that Eikon Therapeutics has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · Quarterly earnings ([filing](https://www.sec.gov/Archives/edgar/data/1861123/0001193125-26-456794.txt))
- Oct 26, 2026 · Clinical trial results ([filing](https://www.sec.gov/Archives/edgar/data/1861123/0001193125-26-430860.txt))
- Oct 23, 2026 · Clinical trial results ([filing](https://www.sec.gov/Archives/edgar/data/1861123/0001193125-26-429549.txt))
- Aug 14, 2026 · Investor presentation ([filing](https://www.sec.gov/Archives/edgar/data/1861123/0001193125-26-349936.txt))
- Aug 3, 2026 · Director departure ([filing](https://www.sec.gov/Archives/edgar/data/1861123/0001193125-26-330710.txt))

## FAQ

### What was the Eikon Therapeutics IPO price?

$18.00 a share.

### When did Eikon Therapeutics go public?

Eikon Therapeutics listed on Nasdaq on Feb 5, 2026 under the ticker EIKN.

### How much did the Eikon Therapeutics IPO raise?

$381.2M, before any underwriters' option.

### How did Eikon Therapeutics open on its first day?

EIKN first traded at $17.05, -5.28% from the IPO price of $18.00.

### How did EIKN close on its first day?

Its last regular-session trade was $14.81, -17.72% from the IPO price of $18.00.

### What was the EIKN first-day trading range?

$14.37 to $17.40 in the regular session.

### How many EIKN shares traded on the first day?

4.41M shares in the regular session.

### How many shares did Eikon Therapeutics sell in its IPO?

21.18M shares.

### How did EIKN do against the market on its first day?

EIKN fell 13.1% from its first trade to the last trade of the session. That is 12.4 points worse than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is EIKN listed on?

Eikon Therapeutics lists on Nasdaq under the ticker EIKN.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=EIKN`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=EIKN`
- `GET https://api.massive.com/v2/aggs/ticker/EIKN/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
